Congenital anomalies are present in at least 10% of all NICU admissions, many of whom have an underlying genetic condition. 1 Neonatologists are often the first physicians to evaluate these infants and consequently need to be familiar with various physical differences to pursue further screening for occult malformations, perform diagnostic testing, and appropriately counsel families. The purpose of this article is review the dysmorphology examination with particular attention to anomalies that are readily apparent in the neonatal period.
An anomaly is a structural defect that deviates from the normal standard and can be categorized as major or minor. A major anomaly has surgical, medical, or cosmetic importance and may be a marker for other occult malformations. A minor anomaly has no significant surgical or cosmetic importance; however, many genetic syndromes are recognized based on the pattern of minor anomalies present. Anomalies arise from 1 of 3 mechanisms, each of which has different diagnostic and inheritance implications. The first mechanism is termed a malformation, which is a structural defect arising from an intrinsically abnormal developmental process. Malformations include anomalies like congenital heart defects and cleft lip and palate. These types of anomalies are more likely associated with a genetic condition or predisposition. A deformation is an abnormality arising from prenatal mechanical forces on otherwise normally formed fetal structures. Deformations can include clubfeet, overlapping toes, and unusual head shape (although these disorders may also be malformations). Deformations are rarely genetic and recurrence risks are typically low. Lastly, disruptions are structural defects resulting from the destruction or interruption of intrinsically normal tissue. Examples of disruptive anomalies include limb reduction defects from amniotic band sequence and certain types of intestinal atresias due to vascular insufficiency. 2 Anomalies due to this mechanism are much less likely due to a genetic condition or to recur in a future pregnancy.
BIRTH PARAMETERS
Both increased and decreased birth parameters are associated with multiple genetic and nongenetic etiologies. Fetal macrosomia may be defined as a birth weight greater than 4000 g or more than 2 SDs above the mean of a reference population, whereas fetal-growth restriction is defined as a birth weight less than 2 SDs below the mean for gestational age in a reference population. The differential diagnoses for both fetal macrosomia and fetal growth restriction are broad and include chromosomal abnormalities and teratogenic exposures. Chromosomal abnormalities have varying phenotypes depending on the size of the chromosomal segment involved and the individual genes in that segment. Consequently, it is beneficial to evaluate for congenital anomalies in those who have macrosomia or growth restriction. In both instances, a chromosomal microarray should be considered. If the physical examination indicates features of a well-characterized genetic syndrome, such as a trisomy or Beckwith-Wiedemann syndrome, then testing can be tailored to that particular syndrome (Tables 1 and 2). [3] [4] [5] [6] [7] [8] Although abnormal birth parameters in the presence of congenital anomalies frequently indicate a genetic syndrome, this is not always the case. For example, infants of diabetic mothers are commonly macrosomic (although growth restriction can also occur) and may display congenital malformations at a frequency of 2 to 4 times the general population rate. Consequently, it may be difficult to distinguish between diabetic embryopathy and a genetic syndrome. 4 In the absence of confirmed maternal diabetes and one of the more specific anomalies seen in diabetic embryopathy, such as caudal regression syndrome or tibial hemimelia with preaxial polydactyly (Fig. 1) , this diagnosis should be considered a diagnosis of exclusion and the clinician should consider further genetic testing, such as a chromosomal microarray, to evaluate for a chromosome abnormality. 2, 3 Similarly, fetal growth restriction can be due to nongenetic causes, such as placental insufficiency, maternal hypertension, multiple gestation (ie, twinning), and maternal preeclampsia. Most of these conditions result in asymmetric growth restriction as a result of inadequate nutrient transfer to the fetus. 9 Placental insufficiency has also been associated with an increased risk of hypospadias in male infants 10 ; therefore, not all birth defects associated with growth restriction are genetic. As with diabetic embryopathy, however, this type of teratogenic mechanism should remain a diagnosis of exclusion and chromosomal microarray in such infants should be considered.
APLASIA CUTIS CONGENITA
Aplasia cutis congenita (ACC) is congenital absence of the skin. Although ACC can occur on any part of the body, it most commonly affects the scalp (70%-80% of Evaluation of the Dysmorphic Infant cases). A majority of cases are sporadic solitary scalp lesions but 15% to 30% of scalp ACC cases are associated with defects in the underlying bone and dura. 11 ACC may be associated with etiologic factors, including birth trauma, intrauterine infections with varicella zoster or herpes viruses, fetus papyraceous, and teratogens, like cocaine and methimazole. 11, 12 ACC has also been associated with multiple genetic conditions, including trisomy 13 and Adams-Oliver syndrome (AOS), a condition characterized by ACC and terminal limb defects. AOS can be inherited in either an autosomal dominant or an autosomal recessive fashion ( Table 3) . 7, 11, 13 Complications of ACC include Table 2 ) (See Table 2 ) (See Table 2 )
Abbreviation: CNS, central nervous system. infection, meningitis, bleeding, and superior sagittal sinus thrombosis. Mortality for those with ACC is 20% to 50% and depends on the size of the lesion and any associated defects. Solitary scalp ACC that is small in size and lateral to the midline usually does not require further diagnostic evaluation per se; however, if a scalp or back defect is midline or membranous in quality, a brain MRI or a spine ultrasound or MRI to evaluate for an underlying neural tube defect should be considered. Treatment of ACC is usually conservative. 11 After healing, areas of scalp affected by ACC do not grow any hair (Fig. 2) .
HOLOPROSENCEPHALY
Holoprosencephaly (HPE) is a structural brain abnormality resulting from the incomplete cleavage of the forebrain into the right and left hemispheres during the third to fourth week of gestation. HPE consists of a continuum of brain malformations with alobar HPE (a single ventricle and no separation of the cerebral hemispheres [ Fig. 3A] ) at one end of the spectrum to very mild midbrain fusion (see Fig. 3B ) at the other end of the spectrum. HPE may be associated with a range of craniofacial abnormalities, including cyclopia, microcephaly, hypotelorism, depressed nasal bridge, single maxillary incisor, and midline cleft lip with or without cleft palate (CLP) ( Fig. 4) . Some affected individuals also have pituitary dysfunction and feeding difficulties. The HPE phenotype is variable among simplex cases and among members of the same family with an inherited form of HPE; consequently, subtle facial features may be overlooked in mildly affected family members. In any infant for whom HPE is considered, first-degree relatives should be questioned and examined to identify those with microcephaly, hypotelorism, or a single central incisor. Due to variable expressivity of the phenotype, affected firstdegree family members may be mildly affected. Because some cases of HPE are inherited in an autosomal dominant fashion, identifying other affected family members has implications for genetic testing and recurrence risks. 14, 15 The etiologies for both syndromic and nonsyndromic HPE are heterogeneous and include maternal diabetes mellitus, single gene disorders (often inherited in an autosomal dominant manner), and chromosomal abnormalities ( Table 4) . 3, 7, 16 Chromosomal abnormalities are present in up to 50% of patients with HPE and include trisomy 13, trisomy 18, and a variety of other copy number variants. Determining which laboratory testing to perform depends on family history and the presence of other 
Evaluation of the Dysmorphic Infant
abnormalities. Testing may include routine chromosome analysis (if trisomy 13 or 18 is suspected) or chromosomal microarray analysis. Further single gene testing may be considered in those with a family history suggestive of an inherited form of HPE, with mutations in SHH accounting for up to 30% to 40% of familial cases. 16 Treatment is multidisciplinary and may include pituitary hormone replacement, antiepileptic medications, and surgical repair of midline CLP in those who are more mildly affected. 15 
ASYMMETRIC CRYING FACIES
Aysmmetric crying facies (ACF) is a minor anomaly, which presents with drooping of the corner of the mouth on the unaffected side when crying or grimacing. Asymmetric crying facies is typically due to congenital absence of the depressor anguli oris muscle (DAOM). Individuals with ACF have preservation of the nasolabial fold depth bilaterally and retain the ability to wrinkle the forehead and to close both eyes equally well, all of which distinguishes this anomaly from the less common facial nerve palsy. 2 ACF has been associated with other congenital anomalies in 20% to 70% of cases. Most anomalies are found in the head/neck and cardiovascular systems but they can also involve the skeletal, genitourinary, and gastrointestinal systems. In particular, ACF has been associated with the 22q11 deletion syndrome (also known as velocardiofacial or DiGeorge syndrome); consequently, individuals with ACF should be evaluated for signs of velocardiofacial syndrome, including dysmorphic facial features, congenital heart defects, and long fingers/toes. Long-term follow-up should focus on evaluation of growth and development and standard treatment of associated anomalies, if present ( Table 5 ). 17, 18 Table 1 ) (See Table 1 ) (See Table 1 )
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(See Table 1 ) (See Table 1 ) (See Table 1 Table 2 ) (See Table 2 ) (See Table 2 ) Table 2 ) (See Table 2 ) (See Table 2 ) 
PREAURICULAR EAR TAGS AND PITS
Preauricular ear tags and pits are frequent findings on routine neonatal physical examinations. Preauricular tags are small, skin-colored nodules that can be found anywhere along a line drawn from the tragus to the angle of the mouth (Fig. 5 ). Preauricular pits are small openings at the anterior margin of the crus of the helix. Both of these anomalies can be found in isolation or as part of a genetic syndrome. All patients with a preauricular tag or pit should have a hearing assessment because abnormalities of the external ear may be associated with middle or inner ear abnormalities and hearing loss. Furthermore, these patients should be examined for any other malformations, which may indicate an underlying genetic syndrome like craniofacial microsomia or branchio-oto-renal syndrome ( Tables 6 and 7) . 2, 19, 20 The association of preauricular ear tags and pits with urinary tract anomalies has also been studied previously. 20, 21 Wang and colleagues 21 suggested renal ultrasound only when ear tags or pits are associated with other malformations or dysmorphic features or if there is a family history of hearing loss, ear anomalies, or maternal gestational diabetes or teratogen exposure. In the absence of these findings, the preauricular tags and pits are presumed isolated and no further evaluation is needed.
OROFACIAL CLEFTING
Orofacial clefts, including CLP and cleft palate only (CP), are the most common craniofacial birth defects in humans, with an incidence of 1 in 700 to 1 in 1000 live births. Subclinical phenotypes may occur and include microform clefts, bifid uvula, submucous CP, and velopharyngeal insufficiency. Most orofacial clefts occur in isolation, presumably due to the combined effect of genetic and environmental factors. Approximately 30% of CLP and 50% of CP are associated, however, with other malformations, most commonly cerebral, dental, and cardiovascular anomalies. 22 The risk of associated anomalies is even higher in the presence of bilateral clefts. Hearing loss also commonly occurs. The constellation of anomalies may indicate an underlying genetic syndrome, which may require further evaluation ( Tables 8 and 9) . 7, 15, 18, [23] [24] [25] [26] [27] The management of a neonate with an orofacial cleft is multidisciplinary with priority given to respiratory and nutritional support. The cleft itself is treated with orthodontic and surgical interventions. Other services, such as speech therapy, and interventions may be required depending on the clinical presentation (see article by Robin and Hamm elsewhere in this issue for a more detailed discussion). 27 
CARDIAC DEFECTS
Congenital heart disease (CHD) is the most common major congenital anomaly seen by neonatologists and a major cause of neonatal morbidity and mortality. There are multiple etiologies for CHD. Isolated CHD is thought to be the result of multifactorial inheritance with both genetic and environmental factors contributing to the malformation. Other CHDs are due to teratogenic effects of infections (eg, rubella and influenza), maternal factors (eg, diabetes mellitus and phenylketonuria), and prenatal exposures (eg, anticonvulsants and alcohol). 3, 28, 29 Genetic etiologies are significant causes of CHD and include trisomies; 45,X (Turner syndrome); chromosomal deletions and/or duplications; and single gene disorders. Although no single cardiac defect is pathognomonic for a particular genetic syndrome, there are certain cardiac defects that are more prevalent in specific syndromes. For example, the 22q11 deletion is present in approximately 50% to 90% of neonates Table 6 ) (See Table 6 ) (See Table 6 )
with an interrupted aortic arch but it is also present in neonates with tetralogy of Fallot, truncus arterious, and ventricular septal defects. Furthermore, many of the patients with CHD and an underlying genetic syndrome have other associated features that help guide further evaluation and testing ( Table 4 ) (See Table 4 ) (See Table 4 Table 2 ) (See Table 2 ) (See Table 2 )
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VENTRAL WALL DEFECTS
Omphalocele and gastroschisis are the most common congenital ventral wall defects.
Omphalocele is a midline defect characterized by eviscerated abdominal contents, which are covered by a protective sac. Omphalocele is associated with other anomalies in up to 90% of cases. Chromosomal abnormalities, including aneuploidies, occur in approximately 20% of cases. 38, 39 Beckwith-Wiedemann syndrome, CHARGE syndrome, and VACTERL association are the most common genetic conditions associated with omphalocele ( Table 12) . [5] [6] [7] 25, 36 In infants with omphalocele, careful examination for other anomalies, including cardiac, renal, and ophthalmologic, should be considered. In the absence of findings that point to a specific syndrome (ie, Beckwith-Wiedemann syndrome), chromosomal microarray testing should be considered.
In contrast, the viscera in gastroschisis are not covered by a sac and protrude through a defect typically located just to the right of the umbilicus. Occasionally the sac covering an omphalocele can rupture, giving the appearance of gastroschisis, but the location of the ventral wall defect can be used to determine whether the most likely diagnosis is a ruptured omphalocele or gastroschisis. Gastroschisis is associated with young maternal age and maternal exposure to tobacco, alcohol, and ibuprofen. Gastroschisis may be associated with intrauterine growth restriction and prematurity. 40 Gastroschisis often occurs as an isolated defect but can have associated anomalies in up to one-third of cases. The most common associated anomalies are intestinal atresias, although musculoskeletal, cardiac, urogenital, and other gastrointestinal defects may be present. 39 For infants who have apparently isolated gastroschisis or gastroschisis associated only with intestinal atresia, genetic testing is typically normal and recurrence risks are low.
POLYDACTYLY
Polydactyly is a common congenital anomaly and can occur on the ulnar (postaxial) or the radial (preaxial) aspects of the extremities. Of the 2 types, postaxial polydactyly is Table 5 ) (See Table 5 ) (See Table 5 Table 5 ) (See Table 5 ) (See Table 5 Table 5 ) (See Table 5 ) (See Table 5 ) Table 11 Tracheoesophageal fistula and associated conditions
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Differential Diagnosis Associated Features Potential Evaluations Potential Genetic Studies
Infant of a diabetic mother (See Table 1 ) (See Table 1 ) (See Table 1 )
Down (trisomy 21) (See Table 10 ) (See Table 10 ) (See Table 10 )
CHARGE (See Table 9 ) (See Table 9 ) (See Table 9 )
Chromosomal abnormalities (See Table 1 ) (See Table 1 ) (See Table 1 Table 2 ) (See Table 2 ) (See Table 2 the most common. Postaxial polydactyly can manifest as a fully developed digit (type A) or as a rudimentary cutaneous appendage (type B). Type B polydactyly generally occurs as an isolated autosomal dominant condition with reduced penetrance. It is more common in African American individuals, with a prevalence of 1 in 143 live births versus 1 in 1339 in white infants. Type B polydactyly frequently occurs bilaterally. It is commonly treated in the nursery with suture ligation. [41] [42] [43] In contrast, preaxial polydactyly is less common, with a prevalence of up to 1 in 3000 live births but occurs more frequently in white infants. It also is associated with an increased incidence of systemic conditions, such as Fanconi anemia, chromosomal abnormalities, and VACTERL association ( Table 13) . 36, 37 Therefore, the finding of preaxial polydactyly should prompt a thorough evaluation for other congenital anomalies and consideration of genetic testing for Fanconi anemia (chromosomal breakage studies) at a minimum. 41, 42 Table 1 ) (See Table 1 ) (See Table 1) CHARGE (See Table 9 ) (See Table 9 ) (See Table 9 ) Trisomy 13 (See Table 2 ) (See Table 2 ) (See Table 2 ) Trisomy 18
(See Table 2 ) (See Table 2 ) (See Table 2 ) VACTERL (See Table 11 ) (See Table 11 ) (See Table 11 Table 11 ) (See Table 11 ) (See Table 11 )
SUMMARY
Neonatologists often have the unique opportunity to be the first to identify abnormalities in the neonate. Once a particular anomaly has been identified in a patient, a thorough examination with particular attention to other associated anomalies should be pursued, taking into consideration a patient's age, gender, race, and family history. Tables 1-13 summarize the anomalies discussed in this review, possible associated syndromes and findings, and suggested investigations. The ability to recognize anomalies and their associated conditions can be the key to the diagnosis and management of a patient and to appropriate recurrence risk counseling for the family.
Best Practices
What is the current practice?
Chromosomal microarray is the recommended first-line test for infants with dysmorphic features that are not specific to a well-recognized genetic syndrome. 44 A genetics consultation should also be considered.
What changes in current practice are likely to improve outcomes?
Making a diagnosis in a child with dysmorphic features enables providers to recognize occult malformations and provide surveillance for complications that may develop over time. It also provides families information regarding the prognosis for their child and recurrence risks for future pregnancies. 2
Major Recommendations
Whenever a dysmorphic feature is recognized, a comprehensive examination for the presence of other anomalies must be undertaken. If there are other features of a well-delineated syndrome present, further evaluation, including a detailed family history, diagnostic studies, and genetic testing, should be pursued (refer to Tables 1-13 for examples and further information).
If features of a well-delineated syndrome are not recognized but there are at least 3 minor anomalies present, further evaluation, including a detailed family history and a chromosomal microarray, should be obtained. Also, the patient should be evaluated for the presence of an occult major malformation, because the presence of 3 or more minor anomalies is associated with a significantly increased risk of the occurrence of an occult major malformation. 2
Rating for the Strength of the Evidence
Chromosomal microarray is the first-line test for infants with dysmorphic features that are not specific to a well-recognized genetic syndrome per the ACMG guidelines. 44 This test has a diagnostic yield of 15% to 20%. 8
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Summary statement
Whenever a dysmorphic feature is recognized, a comprehensive evaluation for the presence of other dysmorphic features and a possible underlying genetic syndrome must be undertaken to help guide management and provide appropriate counseling to the family.
